TY - JOUR
T1 - Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease
AU - Holmans, Peter
AU - Hamshere, Marian
AU - Hollingworth, Paul
AU - Rice, Frances
AU - Tunstall, Nigel
AU - Jones, Sue
AU - Moore, Pamela
AU - Wavrant DeVrieze, Fabienne
AU - Hyers, Amanda
AU - Crook, Richard
AU - Compton, Danielle
AU - Marshall, Helen
AU - Meyer, David
AU - Shears, Shantia
AU - Booth, Jeremy
AU - Ramic, Bzanan
AU - Williams, Nigel
AU - Norton, Nadine
AU - Abraham, Richard
AU - Kehoe, Pat
AU - Williams, Hywel
AU - Rudrasingham, Varuni
AU - O'Donovan, Mick
AU - Jones, Lesley
AU - Hardy, John
AU - Goate, Alison
AU - Lovestone, Simon
AU - Owen, Michael
AU - Williams, Julie
PY - 2005/5/5
Y1 - 2005/5/5
N2 - We performed an affected sib-pair (ASP) linkage analysis to test for the effects of age at onset (AAO), rate of decline (ROD), and Apolipoprotein E (APOE) genotype on linkage to late-onset Alzheimer's disease (AD) in a sample comprising 428 sib-pairs. We observed linkage of mean AAO to chromosome 21 in the whole sample (max LOD = 2.57). This came entirely from the NIMH sample (max LOD = 3.62), and was strongest in pairs with high mean AAO (>80). A similar effect was observed on chromosome 2q in the MMH sample (max LOD = 2.73); this region was not typed in the IADC/UK sample. Suggestive evidence was observed in the combined sample of linkage of AAO difference to chromosome 19q (max LOD = 2.33) in the vicinity of APOE and 12p (max LOD = 2.22), with linkage strongest in sib-pairs with similar AAO. Mean ROD showed suggestive evidence of linkage to chromosome 9q in the whole sample (max LOD = 2.29), with the effect strongest in the MMH sample (max LOD = 3.58), and in pairs with high mean ROD. Additional suggestive evidence was also observed in the NIMH sample with AAO difference on chromosome 6p (max LOD = 2.44) and 15p (max LOD = 1.87), with linkage strongest in pairs with similar AAO, and in the UK sample with mean ROD on chromosome 1p (max LOD = 2.73, linkage strongest in pairs with high mean ROD). We also observed suggestive evidence of increased identical by descent (IBD) in APOE ε4 homozygotes on chromosome 1 (max LOD = 3.08) and chromosome 9 (max LOD = 3.34). The previously reported genome-wide linkage of AD to chromosome 10 was not influenced by any of the covariates studied.
AB - We performed an affected sib-pair (ASP) linkage analysis to test for the effects of age at onset (AAO), rate of decline (ROD), and Apolipoprotein E (APOE) genotype on linkage to late-onset Alzheimer's disease (AD) in a sample comprising 428 sib-pairs. We observed linkage of mean AAO to chromosome 21 in the whole sample (max LOD = 2.57). This came entirely from the NIMH sample (max LOD = 3.62), and was strongest in pairs with high mean AAO (>80). A similar effect was observed on chromosome 2q in the MMH sample (max LOD = 2.73); this region was not typed in the IADC/UK sample. Suggestive evidence was observed in the combined sample of linkage of AAO difference to chromosome 19q (max LOD = 2.33) in the vicinity of APOE and 12p (max LOD = 2.22), with linkage strongest in sib-pairs with similar AAO. Mean ROD showed suggestive evidence of linkage to chromosome 9q in the whole sample (max LOD = 2.29), with the effect strongest in the MMH sample (max LOD = 3.58), and in pairs with high mean ROD. Additional suggestive evidence was also observed in the NIMH sample with AAO difference on chromosome 6p (max LOD = 2.44) and 15p (max LOD = 1.87), with linkage strongest in pairs with similar AAO, and in the UK sample with mean ROD on chromosome 1p (max LOD = 2.73, linkage strongest in pairs with high mean ROD). We also observed suggestive evidence of increased identical by descent (IBD) in APOE ε4 homozygotes on chromosome 1 (max LOD = 3.08) and chromosome 9 (max LOD = 3.34). The previously reported genome-wide linkage of AD to chromosome 10 was not influenced by any of the covariates studied.
KW - Age at onset
KW - Alzheimer's Disease
KW - Genome screen
KW - Linkage
KW - Rate of decline
UR - http://www.scopus.com/inward/record.url?scp=20244364113&partnerID=8YFLogxK
U2 - 10.1002/ajmg.b.30114
DO - 10.1002/ajmg.b.30114
M3 - Article
C2 - 15729734
AN - SCOPUS:20244364113
SN - 1552-4841
VL - 135 B
SP - 24
EP - 32
JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
IS - 1
ER -